Dr Reddys unveils generic Fulvestrant injection for breast cancer in US
Faslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.
New Delhi: Pharma major Dr. Reddy''s Laboratories on Monday said it has launched a generic Fulvestrant injection, used for the treatment of advanced breast cancer, in the US market.
The company has launched Fulvestrant injection, 250 mg/5 mL (50 mg/mL) per single-dose syringe, approved by the United States Food and Drug Administration (USFDA), Dr Reddy''s Laboratories said in a filing to BSE.
The product is a generic version of Faslodex injection in the same strength, it added.
According to the IQVIA Health data, Faslodex brand and generic market had US sales of around USD 407 million MAT for 12 months to June 2020, the filing said.
Read also: Dr Reddys launches generic version of Cuprimine Capsules in US
Faslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.
Shares of Dr. Reddy''s Laboratories closed at Rs 4,422.25 on BSE, up 2.29 percent from the previous close.
Read also: Dr. Reddys unveils Methylphenidate Hydrochloride ER Tablets in US
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.